Recent News

AffyImmune Therapeutics to Present Initial Clinical Results at Upcoming CAR-TCR Summit

NATICK, Mass. (AUGUST 19, 2021) – AffyImmune Therapeutics, Inc., a clinical stage biotechnology company finding safe, effective ways to use CAR T cells against solid cancers, announced today that scientific co-founder Moonsoo Jin will present twice at Hanson Wade’s 6<sup>th</sup> CAR-TCR Summit being held virtually August 30 – September 2. [...]

AffyImmune Therapeutics Announces Hiring of Matt Britz as Senior Vice President of Business Development

NATICK, Mass., June 21, 2021 /PRNewswire/ -- AffyImmune Therapeutics, Inc., a clinical stage biotechnology company finding safe, effective ways to use CAR-T cells against solid cancers, announced today the addition of Matt Britz to its management team as its Senior Vice President of Business Development. "Matt brings deep industry experience, [...]

Events

There are no events at this time.